StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Longeveron gross margin

Gross margin is gross profit as a percentage of revenue.

Longeveron's gross margin for the twelve months ending Jun 30, 2026 was 69.8%. For fiscal 2025 it was 67.0%, against 78.8% the year before. The highest annual figure on record is 78.8% in fiscal 2024.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202567.0%−11.8
FY2024Dec 31, 202478.8%+47.6
FY2023Dec 31, 202331.2%−9.5
FY2022Dec 31, 202240.7%−4.5
FY2021Dec 31, 202145.2%+12.7
FY2020Dec 31, 202032.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202663.4%+17.2
Q1 FY2026Mar 31, 202666.3%−5.8
Q4 FY2025Dec 31, 202570.4%−17.5
Q3 FY2025Sep 30, 202591.2%+3.0
Q2 FY2025Jun 30, 202546.2%−27.3
Q1 FY2025Mar 31, 202572.2%+12.1
Q4 FY2024Dec 31, 202487.9%+91.1
Q3 FY2024Sep 30, 202488.2%+52.2
Q2 FY2024Jun 30, 202473.5%+30.6
Q1 FY2024Mar 31, 202460.0%+32.8
Q4 FY2023Dec 31, 2023-3.2%−37.5
Q3 FY2023Sep 30, 202336.0%−8.6
Q2 FY2023Jun 30, 202342.9%+9.8
Q1 FY2023Mar 31, 202327.2%−43.4
Q2 FY2022Jun 30, 202234.3%−8.2
Q1 FY2022Mar 31, 202244.6%+5.0
Q4 FY2021Dec 31, 202133.0%−11.8
Q3 FY2021Sep 30, 202170.7%+50.7
Q2 FY2021Jun 30, 202142.5%+29.8
Q1 FY2021Mar 31, 202139.6%−7.9
Q4 FY2020Dec 31, 202044.8%–
Q3 FY2020Sep 30, 202020.0%–
Q2 FY2020Jun 30, 202012.8%–
Q1 FY2020Mar 31, 202047.5%–

More Longeveron figures

See a number that looks wrong?